The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.
Daniel CassarManuela RadicMaurizio CasarrubeaVincenzo CrunelliGiuseppe Di GiovanniPublished in: CNS neuroscience & therapeutics (2022)
GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze.